Indaptus Therapeutics Provides Clinical Update
IDPT(IDPT) Decoy20 monotherapy induces Partial Response in patient with urothelial cancer and liver metastases
September 4, 2025Clinical Trials
Read more →(IDPT) Decoy20 monotherapy induces Partial Response in patient with urothelial cancer and liver metastases